The Brain in Pain study seeks to better understand changes in brain chemistry that might explain the pain in Fibromyalgia and Chronic Fatigue Syndrome. To do this, the study will be using a method of brain scanning that enables us to look at which parts of the brain and which chemicals are active during pain.
The study is based in London and is actively recruiting patients with Fibromyalgia or Chronic Fatigue Syndrome who are NOT currently on ‘centrally acting’ medications (including the following Gabapentin, Pregabalin and antidepressants such as Duloxetine and Amitriptyline) or chronic Opiate treatment. The study will reimburse participants for their time.
If you are interested in taking part, further information can be obtained from Dr Bourke using the following email address : j.bourke@qmul.ac.uk.